Core Capital Management & Research, inc.’s Merck MRK Stock Holding History

Core Capital Management & Research, inc.’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$19.9K	Buy	+132	New	+$15.4K	0.01%	143

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Core Capital Management & Research, inc.'s MRK Position: Q2 2026 in Review

Core Capital Management & Research, inc. opened a new position in Merck (MRK) in Q2 2026: 132 shares worth $19.9K. The stake represents 0.01% of the portfolio and ranks #143 among its holdings.

3,836 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Core Capital Management & Research, inc. held 132 shares of Merck worth $19.9K as of Q2 2026.
Merck was a new Core Capital Management & Research, inc. position in Q2 2026.
Merck made up 0.01% of Core Capital Management & Research, inc.'s portfolio in Q2 2026, its #143 holding.
3,836 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Core Capital Management & Research, inc.'s 13F filing for Q2 2026, filed 9 Sep 2026.